CCC
IDXX icon

Chesapeake Capital Corp’s Idexx Laboratories IDXX Stock Holding History

Chesapeake Capital Corp’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
625
-141
-18% -$79.1K 0.17% 151
2026
Q1 		$430K Sell
766
-223
-23% -$143K 0.31% 123
2025
Q4 		$669K Hold
989
– – 0.56% 77
2025
Q3 		$632K Buy
+989
New +$600K 0.57% 81

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Chesapeake Capital Corp's IDXX Position: Q2 2026 in Review

Chesapeake Capital Corp reduced its Idexx Laboratories (IDXX) stake by 18% in Q2 2026, selling an estimated $79.1K and leaving 625 shares worth $329K. The position accounts for 0.17% of the portfolio, ranked #151.

Chesapeake Capital Corp first reported a position in IDXX in Q3 2025 and has held it in 4 quarters since. The position peaked at $669K in Q4 2025. 512 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Chesapeake Capital Corp held 625 shares of Idexx Laboratories worth $329K as of Q2 2026.
  • Chesapeake Capital Corp sold 141 Idexx Laboratories shares in Q2 2026, an estimated $79.1K.
  • Idexx Laboratories made up 0.17% of Chesapeake Capital Corp's portfolio in Q2 2026, its #151 holding.
  • Chesapeake Capital Corp first reported a position in Idexx Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Chesapeake Capital Corp's Idexx Laboratories position peaked at $669K in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.